Biotech Week Boston highlights research progress in cell and gene therapy

By Samantha Black, PhD, The Science Advisory Board editor in chief

At Biotech Week Boston, ScienceBoard.net spoke with experts in cell and gene therapy technologies.

Biotech Week Boston is a collection of several industry-leading events, including BioProcess International, Cell & Gene Therapy Manufacturing & Commercialization US, and TIDES USA. The event was held at the Boston Convention Center from September 21-23. In attendance were life science professionals with expertise in discovery, financing, manufacturing, and clinical trials.

Video loading ...

We caught up with the following experts:

  • Stefano Menegatti, associate professor at North Carolina State University
  • Armon Sharei, founder and CEO of SQZ Biotech
  • Fabian Gerlinghaus, co-founder and CEO of Cellares
  • Andrew Tustian, director of viral process development at Regeneron Pharmaceuticals

High-throughput analysis speeds downstream process development
Adding high-throughput analysis helped speed up downstream process development for drug candidates based on monoclonal antibodies, according to a case...
Optofluidics aids cell line development for antibody-based therapies
Implementation of optofluidics in cell line development can help advance multiple lead candidate molecules with increased screening capacity. A researcher...

Copyright © 2021 scienceboard.net


Conferences
Interphex 2021
October 19-21
New York City, New York United States
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter